Establishment Labs Holdings vs Lemaitre Vascular
Lemaitre Vascular is the larger business, with $250m of revenue in fiscal 2025 against $211m for Establishment Labs Holdings (1.2 times as much). Establishment Labs Holdings grew faster (27.1% against 13.5%). Lemaitre Vascular kept more of each dollar of sales as profit: a net margin of 23.1% against -24.2%. Lemaitre Vascular carries less debt relative to equity (42.9% against 1051.2%).
| Latest fiscal year | Establishment Labs HoldingsESTA, 2025 | Lemaitre VascularLMAT, 2025 |
|---|---|---|
| Revenue | $211m | $250m |
| Revenue growth | 27.1% | 13.5% |
| Net income | −$51.1m | $57.7m |
| Operating margin | -18.5% | 27.2% |
| Net margin | -24.2% | 23.1% |
| Return on equity | -133.3% | 15.8% |
| Free cash flow | −$56.9m | $74.5m |
| Cash | $75.6m | $28.2m |
| Total debt | $248m | $169m |
| Debt to equity | 1051.2% | 42.9% |
| Dividend per share | — | $0.80 |
| Dividend yield | — | 1.1% |
| Share buybacks | — | $1.8m |
| Employees | 1,004 | 655 |
| Market value | $1.82bn | $1.85bn |
| Price vs our value range | — | Within our value range |
| Moat score | 31 (Weak) | 86 (Strong) |
| Insider trades, 12 months | 0 buys, 30 sales | 0 buys, 11 sales |